Aclaris Therapeutics's total assets for Q3 2024 were $182.39M, an increase of 13.24% from the previous quarter. ACRS total liabilities were $52.24M for the fiscal quarter, a 91.72% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.